PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramit Walia PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parmjeet Kaurand Jasjot Singh PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Galaxy Vitacare Pvt Ltd PRISM MEDICO AND PHARMACY LTD. - 512217 - Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the details of Related Party Transactions (RPT's) for the half year ended 31st March, 2023. You are requested to kindly take the same on record and oblige. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 30th May, 2023) which commenced at 04:30 P.M. and concluded at 06:30 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record and oblige. PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd & Jasjot Singh, Symbiosis Pharmaceuticals Pvt Ltd, Galaxy Vitacare Pvt Ltd PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Galaxy Vitacare Pvt Ltd PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Symbiosis Pharmaceuticals Pvt Ltd PRISM MEDICO AND PHARMACY LTD. - 512217 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd & Jasjot Singh